Characterization of amyloid formation by glucagon-like peptides: Role of basic residues in heparin-mediated aggregation

Biochemistry

Volumn 52, Issue 49, 2013, Pages 8800-8810

  Jha, Narendra Nath ^a   Anoop, A ^a   Ranganathan, Srivastav ^a   Mohite, Ganesh M ^a   Padinhateeri, Ranjith ^a   Maji, Samir K ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATION KINETICS; AMYLOID FORMATION; BIOLOGICAL FUNCTIONS; COMPUTATIONAL APPROACH; GLYCOSAMINOGLYCANS; PROTEIN AGGREGATION; PROTEINS/PEPTIDES; SPECIFIC NATURE;

GLYCOPROTEINS; PEPTIDES;

POLYSACCHARIDES;

AMYLOID; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; HEPARIN;

ARTICLE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

EID: 84890504484     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi401398k     Document Type: Article

References (69)

1. Chiti, F. and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75, 333-366
2. Fowler, D. M., Koulov, A. V., Balch, W. E., and Kelly, J. W. (2007) Functional amyloid-from bacteria to humans Trends Biochem. Sci. 32, 217-224
3. Fowler, D. M., Koulov, A. V., Alory-Jost, C., Marks, M. S., Balch, W. E., and Kelly, J. W. (2006) Functional amyloid formation within mammalian tissue PLoS Biol. 4, e6
4. Maji, S. K., Perrin, M. H., Sawaya, M. R., Jessberger, S., Vadodaria, K., Rissman, R. A., Singru, P. S., Nilsson, K. P., Simon, R., Schubert, D., Eisenberg, D., Rivier, J., Sawchenko, P., Vale, W., and Riek, R. (2009) Functional amyloids as natural storage of peptide hormones in pituitary secretory granules Science 325, 328-332
5. Kelly, R. B. (1985) Pathways of protein secretion in eukaryotes Science 230, 25-32
6. Arvan, P. and Castle, D. (1998) Sorting and storage during secretory granule biogenesis: Looking backward and looking forward Biochem. J. 332, 593-610
7. Dannies, P. S. (2001) Concentrating hormones into secretory granules: Layers of control Mol. Cell. Endocrinol. 177, 87-93
8. Dannies, P. S. (2002) Mechanisms for storage of prolactin and growth hormone in secretory granules Mol. Genet. Metab. 76, 6-13
9. Tooze, S. A. (1998) Biogenesis of secretory granules in the trans-Golgi network of neuroendocrine and endocrine cells Biochim. Biophys. Acta 1404, 231-244
10. Anderson, R. G. and Pathak, R. K. (1985) Vesicles and cisternae in the trans Golgi apparatus of human fibroblasts are acidic compartments Cell 40, 635-643
11. Jain, R. K., Joyce, P. B., and Gorr, S. U. (2000) Aggregation chaperones enhance aggregation and storage of secretory proteins in endocrine cells J. Biol. Chem. 275, 27032-27036
12. Ranganathan, S., Singh, P. K., Singh, U., Singru, P. S., Padinhateeri, R., and Maji, S. K. (2012) Molecular interpretation of ACTH-β-endorphin coaggregation: Relevance to secretory granule biogenesis PLoS One 7, e31924-1-e31924-12
13. Maji, S. K. and Riek, R. (2010) Formation of secretory granules involve the amyloid structure, in Functional Amyloid Aggregation (Rigacci, S. and Bucciantini, M., Eds.) pp 135-155, Research Signpost, Kerala, India.
14. Kolset, S. O., Prydz, K., and Pejler, G. (2004) Intracellular proteoglycans Biochem. J. 379, 217-227
15. Reggio, H. A. and Palade, G. E. (1978) Sulfated compounds in the zymogen granules of the guinea pig pancreas J. Cell Biol. 77, 288-314
16. Carlson, S. S. and Kelly, R. B. (1983) A highly antigenic proteoglycan-like component of cholinergic synaptic vesicles J. Biol. Chem. 258, 11082-11091
17. Su, J. H., Cummings, B. J., and Cotman, C. W. (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease Neuroscience 51, 801-813
18. Cohlberg, J. A., Li, J., Uversky, V. N., and Fink, A. L. (2002) Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro Biochemistry 41, 1502-1511
19. Snow, A. D., Kisilevsky, R., Willmer, J., Prusiner, S. B., and DeArmond, S. J. (1989) Sulfated glycosaminoglycans in amyloid plaques of prion diseases Acta Neuropathol. 77, 337-342
20. Athanasou, N. A., West, L., Sallie, B., and Puddle, B. (1995) Localized amyloid deposition in cartilage is glycosaminoglycans-associated Histopathology 26, 267-272
21. Athanasou, N. A., Kokubun, S., West, L., Sallie, B., and Puddle, B. (1995) Glycosaminoglycans in intervertebral disc amyloid deposits Eur. Spine J. 4, 308-312
22. Valle-Delgado, J. J., Alfonso-Prieto, M., de Groot, N. S., Ventura, S., Samitier, J., Rovira, C., and Fernandez-Busquets, X. (2010) Modulation of Aβ42 fibrillogenesis by glycosaminoglycan structure FASEB J. 24, 4250-4261
23. Suk, J. Y., Zhang, F., Balch, W. E., Linhardt, R. J., and Kelly, J. W. (2006) Heparin accelerates gelsolin amyloidogenesis Biochemistry 45, 2234-2242
24. Bourgault, S., Solomon, J. P., Reixach, N., and Kelly, J. W. (2011) Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion Biochemistry 50, 1001-1015
25. Cardin, A. D. and Weintraub, H. J. (1989) Molecular modeling of protein-glycosaminoglycan interactions Arteriosclerosis 9, 21-32
26. Vilasi, S., Sarcina, R., Maritato, R., De Simone, A., Irace, G., and Sirangelo, I. (2011) Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro PLoS One 6, e22076-1-e22076-13
27. Noborn, F., O'Callaghan, P., Hermansson, E., Zhang, X., Ancsin, J. B., Damas, A. M., Dacklin, I., Presto, J., Johansson, J., Saraiva, M. J., Lundgren, E., Kisilevsky, R., Westermark, P., and Li, J. P. (2011) Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein Proc. Natl. Acad. Sci. U.S.A. 108, 5584-5589
28. Fowlkes, J. L., Thrailkill, K. M., George-Nascimento, C., Rosenberg, C. K., and Serra, D. M. (1997) Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation Endocrinology 138, 2280-2285
29. Ghodke, S., Nielsen, S. B., Christiansen, G., Hjuler, H. A., Flink, J., and Otzen, D. (2012) Mapping out the multistage fibrillation of glucagon FEBS J. 279, 752-765
30. Andersen, C. B., Hicks, M. R., Vetri, V., Vandahl, B., Rahbek-Nielsen, H., Thogersen, H., Thogersen, I. B., Enghild, J. J., Serpell, L. C., Rischel, C., and Otzen, D. E. (2010) Glucagon fibril polymorphism reflects differences in protofilament backbone structure J. Mol. Biol. 397, 932-946
31. Andersen, C. B., Otzen, D., Christiansen, G., and Rischel, C. (2007) Glucagon amyloid-like fibril morphology is selected via morphology-dependent growth inhibition Biochemistry 46, 7314-7324
32. Pedersen, J. S., Flink, J. M., Dikov, D., and Otzen, D. E. (2006) Sulfates dramatically stabilize a salt-dependent type of glucagon fibrils Biophys. J. 90, 4181-4194
33. Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., and Habener, J. F. (1986) Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing J. Biol. Chem. 261, 11880-11889
34. Kieffer, T. J. and Habener, J. F. (1999) The glucagon-like peptides Endocr. Rev. 20, 876-913
35. Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kale, L., and Schulten, K. (2005) Scalable molecular dynamics with NAMD J. Comput. Chem. 26, 1781-1802
36. Willander, H., Presto, J., Askarieh, G., Biverstal, H., Frohm, B., Knight, S. D., Johansson, J., and Linse, S. (2012) BRICHOS domains efficiently delay fibrillation of amyloid beta-peptide J. Biol. Chem. 287, 31608-31617
37. (2010) The PyMOL Molecular Graphics System, Version 1.3r1, Schrödinger, LLC, Porland, OR.
38. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., and Ferrin, T. E. (2004) UCSF Chimera-a visualization system for exploratory research and analysis J. Comput. Chem. 25, 1605-1612
39. Wallace, A. C., Laskowski, R. A., and Thornton, J. M. (1995) LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions Protein Eng. 8, 127-134
40. Biancalana, M., Makabe, K., Koide, A., and Koide, S. (2009) Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide self-assemblies J. Mol. Biol. 385, 1052-1063
41. Ban, T., Hamada, D., Hasegawa, K., Naiki, H., and Goto, Y. (2003) Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence J. Biol. Chem. 278, 16462-16465
42. Ferrone, F. (1999) Analysis of protein aggregation kinetics Methods Enzymol 309, 256-274
43. Naiki, H., Higuchi, K., Nakakuki, K., and Takeda, T. (1991) Kinetic analysis of amyloid fibril polymerization in vitro Lab. Invest. 65, 104-110
44. Pedersen, J. S. and Otzen, D. E. (2008) Amyloid-a state in many guises: Survival of the fittest fibril fold Protein Sci. 17, 2-10
45. LeVine, H., 3rd (1993) Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution Protein Sci. 2, 404-410
46. Maji, S. K., Ogorzalek Loo, R. R., Inayathullah, M., Spring, S. M., Vollers, S. S., Condron, M. M., Bitan, G., Loo, J. A., and Teplow, D. B. (2009) Amino acid position-specific contributions to amyloid β-protein oligomerization J. Biol. Chem. 284, 23580-23591
47. Brahms, S. and Brahms, J. (1980) Determination of protein secondary structure in solution by vacuum ultraviolet circular dichroism J. Mol. Biol. 138, 149-178
48. McCubbin, W. D., Kay, C. M., Narindrasorasak, S., and Kisilevsky, R. (1988) Circular-dichroism studies on two murine serum amyloid A proteins Biochem. J. 256, 775-783
49. Kaylor, J., Bodner, N., Edridge, S., Yamin, G., Hong, D. P., and Fink, A. L. (2005) Characterization of oligomeric intermediates in alpha-synuclein fibrillation: FRET studies of Y125W/Y133F/Y136F α-synuclein J. Mol. Biol. 353, 357-372
50. Cheon, M., Chang, I., Mohanty, S., Luheshi, L. M., Dobson, C. M., Vendruscolo, M., and Favrin, G. (2007) Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils PLoS Comput. Biol. 3, 1727-1738
51. Khurana, R., Gillespie, J. R., Talapatra, A., Minert, L. J., Ionescu-Zanetti, C., Millett, I., and Fink, A. L. (2001) Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates Biochemistry 40, 3525-3535
52. Lakowicz, J. R. (2006) Protein fluorescence, in Principles of Fluorescence Spectroscopy, 3 rd ed., pp 529-575, Springer, New York.
53. McLaurin, J., Franklin, T., Zhang, X., Deng, J., and Fraser, P. E. (1999) Interactions of Alzheimer amyloid-β peptides with glycosaminoglycans effects on fibril nucleation and growth Eur. J. Biochem. 266, 1101-1110
54. Motamedi-Shad, N., Monsellier, E., and Chiti, F. (2009) Amyloid formation by the model protein muscle acylphosphatase is accelerated by heparin and heparan sulphate through a scaffolding-based mechanism J. Biochem. 146, 805-814
55. Klimov, D. K. and Thirumalai, D. (2003) Dissecting the assembly of Aβ16-22 amyloid peptides into antiparallel beta sheets Structure 11, 295-307
56. Cruz, L., Urbanc, B., Borreguero, J. M., Lazo, N. D., Teplow, D. B., and Stanley, H. E. (2005) Solvent and mutation effects on the nucleation of amyloid β-protein folding Proc. Natl. Acad. Sci. U.S.A. 102, 18258-18263
57. Urbanc, B., Cruz, L., Yun, S., Buldyrev, S. V., Bitan, G., Teplow, D. B., and Stanley, H. E. (2004) In silico study of amyloid β-protein folding and oligomerization Proc. Natl. Acad. Sci. U.S.A. 101, 17345-17350
58. Ma, B. and Nussinov, R. (2006) Simulations as analytical tools to understand protein aggregation and predict amyloid conformation Curr. Opin. Chem. Biol. 10, 445-452
59. Timmer, N. M., Schirris, T. J., Bruinsma, I. B., Otte-Holler, I., van Kuppevelt, T. H., de Waal, R. M., and Verbeek, M. M. (2010) Aggregation and cytotoxic properties towards cultured cerebrovascular cells of Dutch-mutated Aβ40 (DAβ(1-40)) are modulated by sulfate moieties of heparin Neurosci. Res. 66, 380-389
60. Diaz-Nido, J., Wandosell, F., and Avila, J. (2002) Glycosaminoglycans and β-amyloid, prion and tau peptides in neurodegenerative diseases Peptides 23, 1323-1332
61. McLaurin, J. and Fraser, P. E. (2000) Effect of amino-acid substitutions on Alzheimer's amyloid-β peptide-glycosaminoglycan interactions Eur. J. Biochem. 267, 6353-6361
62. Fraser, P. E., Nguyen, J. T., Chin, D. T., and Kirschner, D. A. (1992) Effects of sulfate ions on Alzheimer β/A4 peptide assemblies: Implications for amyloid fibril-proteoglycan interactions J. Neurochem. 59, 1531-1540
63. Yamaguchi, I., Suda, H., Tsuzuike, N., Seto, K., Seki, M., Yamaguchi, Y., Hasegawa, K., Takahashi, N., Yamamoto, S., Gejyo, F., and Naiki, H. (2003) Glycosaminoglycan and proteoglycan inhibit the depolymerization of β2-microglobulin amyloid fibrils in vitro Kidney Int. 64, 1080-1088
64. Castillo, G. M., Lukito, W., Wight, T. N., and Snow, A. D. (1999) The sulfate moieties of glycosaminoglycans are critical for the enhancement of β-amyloid protein fibril formation J. Neurochem. 72, 1681-1687
65. Fernandez-Escamilla, A. M., Rousseau, F., Schymkowitz, J., and Serrano, L. (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins Nat. Biotechnol. 22, 1302-1306
66. Poon, S., Birkett, N. R., Fowler, S. B., Luisi, B. F., Dobson, C. M., and Zurdo, J. (2009) Amyloidogenicity and aggregate cytotoxicity of human glucagon-like peptide-1 (hGLP-1) Protein Pept. Lett. 16, 1548-1556
67. Wong, S. and Kisilevsky, R. (1990) Influence of sulphate ions on the structure of AA amyloid fibrils Scand. J. Immunol. 32, 225-232
68. Snow, A. D., Willmer, J., and Kisilevsky, R. (1987) Sulfated glycosaminoglycans: A common constituent of all amyloids? Lab. Invest. 56, 120-123
69. Bonifacio, M. J., Sakaki, Y., and Saraiva, M. J. (1996) 'In vitro' amyloid fibril formation from transthyretin: The influence of ions and the amyloidogenicity of TTR variants Biochim. Biophys. Acta 1316, 35-42 Science and Technology Science and Technology Science and Technology